↓ Skip to main content

Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in…

Overview of attention for article published in European Journal of Pharmaceutics & Biopharmaceutics, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice
Published in
European Journal of Pharmaceutics & Biopharmaceutics, April 2019
DOI 10.1016/j.ejpb.2019.02.013
Pubmed ID
Authors

Xue Luan, Kamil Rahme, Zhongcheng Cong, Limei Wang, Yifang Zou, Yan He, Hao Yang, Justin D. Holmes, Caitriona M. O'Driscoll, Jianfeng Guo

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 19%
Student > Bachelor 6 19%
Student > Master 6 19%
Researcher 4 13%
Professor 1 3%
Other 3 9%
Unknown 6 19%
Readers by discipline Count As %
Chemistry 5 16%
Pharmacology, Toxicology and Pharmaceutical Science 5 16%
Agricultural and Biological Sciences 4 13%
Nursing and Health Professions 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Other 6 19%
Unknown 8 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2019.
All research outputs
#8,572,659
of 16,585,337 outputs
Outputs from European Journal of Pharmaceutics & Biopharmaceutics
#1,093
of 1,868 outputs
Outputs of similar age
#113,986
of 271,340 outputs
Outputs of similar age from European Journal of Pharmaceutics & Biopharmaceutics
#11
of 30 outputs
Altmetric has tracked 16,585,337 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,868 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,340 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.